1. Home
  2. ANDE vs DNTH Comparison

ANDE vs DNTH Comparison

Compare ANDE & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$63.95

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$65.19

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANDE
DNTH
Founded
1947
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
ANDE
DNTH
Price
$63.95
$65.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$75.00
$82.33
AVG Volume (30 Days)
262.9K
647.1K
Earning Date
05-20-2026
04-06-2026
Dividend Yield
1.26%
N/A
EPS Growth
12.93
69.82
EPS
0.82
N/A
Revenue
$11,008,928,000.00
$6,235,000.00
Revenue This Year
$13.28
N/A
Revenue Next Year
$5.76
N/A
P/E Ratio
$77.63
N/A
Revenue Growth
N/A
120.63
52 Week Low
$31.03
$13.37
52 Week High
$70.06
$64.67

Technical Indicators

Market Signals
Indicator
ANDE
DNTH
Relative Strength Index (RSI) 49.43 76.23
Support Level $62.90 $33.94
Resistance Level $70.06 N/A
Average True Range (ATR) 2.26 3.69
MACD -0.59 1.23
Stochastic Oscillator 28.93 98.34

Price Performance

Historical Comparison
ANDE
DNTH

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: